1.
Isis Pharmaceuticals, Inc.
Discovers and develops drugs based upon antisense and RNAi technology. Focused on RNA as a therapeutic target. Includes overview of recent research and drug ... Show stock quote for ISIS
2.
Isis Pharmaceuticals, Inc.
Discovers and develops drugs based upon antisense and RNAi technology. Focused on RNA as a therapeutic target. Includes overview of recent research and drug ... Show stock quote for ISIS
3.
Untitled Document
By targeting cells expressing abnormal levels of PKC-alpha Affinitak may have ... Affinitak, an inhibitor of PKC-alpha, is in a Phase III trial for ...
4.
Isis Pharmaceuticals | Management Bios - Print
Stanley T. Crooke, M.D., Ph.D. Dr. Crooke is Founder, Chairman and Chief Executive Officer of Isis Pharmaceuticals. Isis is a development stage ...
5.
Isis Pharmaceuticals, Inc.
Discovers and develops drugs based upon antisense and RNAi technology. Focused on RNA as a therapeutic target. Includes overview of recent research and drug ... Show stock quote for ISIS
6.
Isis Pharmaceuticals | Product Pipeline
Lowering cholesterol is a key component in preventing and managing .... ISIS 113715 is currently in Phase 2 development for the treatment of type 2 diabetes ...
7.
Isis Pharmaceuticals | Employment
At Isis we strive for a culture that promotes scientific excellence, hard work, creativity, and diversity. Our mission is to help people through the ...
8.
Isis Pharmaceuticals, Inc.
Discovers and develops drugs based upon antisense and RNAi technology. Focused on RNA as a therapeutic target. Includes overview of recent research and drug ... Show stock quote for ISIS
9.
Isis Pharmaceuticals | Employment
We appreciate your interest in Isis Pharmaceuticals and invite you to review our ... Isis Pharmaceuticals, Inc. is proud to be an EEO/AA M/F D/V employer.
10.
Isis Pharmaceuticals, Inc.
Discovers and develops drugs based upon antisense and RNAi technology. Focused on RNA as a therapeutic target. Includes overview of recent research and drug ... Show stock quote for ISIS
